Last Posted: Nov 08, 2019
- Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.
Onengut-Gumuscu Suna et al. Diabetes care 2019 42(3) 406-415 - Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes.
Climent Elisenda et al. Revista espanola de cardiologia (English ed.) 2019 Oct - High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain.
Xu Yuanwei et al. PLoS medicine 2019 Oct 16(10) e1002961 - Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care.
Riddle Matthew C et al. Diabetes care 2019 Jun 42(6) 1136-1146 - Development of a Deep Learning Model for Dynamic Forecasting of Blood Glucose Level for Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Controlled Trial.
Faruqui Syed Hasib Akhter et al. JMIR mHealth and uHealth 2019 Nov 7(11) e14452 - Polygenic risk scores predict diabetic complications and their response to therapy
J Tremblay et al, MedRXIV, November 1, 2019 - FDA approves new breakthrough therapy for cystic fibrosis- Treatment approved for approximately 90% of patients with cystic fibrosis, many of whom had no approved therapeutic options
FDA News Release, October 2019 - New Hope For Patients Living With Cystic Fibrosis After Scientists Unveil Therapy
NPR, November 1, 2019 - Polygenic Risk Scoring: An Epidemiologist?s Perspective
C Janssens, podcast, October 2019 - Diagnosis and Treatment of Genetic HFE -Hemochromatosis: The Danish Aspect.
Milman Nils Thorm et al. Gastroenterology research 2019 Oct 12(5) 221-232
.png)
No hay comentarios:
Publicar un comentario